Studies demonstrate that A20+/- mice display exacerbated psoriasis-like skin inflammation upon imiquimod (IMQ) challenge, highlighting the role of A20 haploinsufficiency in amplifying inflammatory responses (36, 71). This evidence concerns the gene TNFAIP3 and dermatitis.